在CAR-T细胞治疗中克服抗原异质性的策略
Bohan Zhang1, Jiawen Wu1, Hua Jiang1,2
1State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China.
Cells
|March 12, 2025
概括
化学抗原受体 (CAR) T细胞治疗由于瘤细胞抗原差异而面临挑战. 结合疗法和多目标CAR等策略旨在克服这种异质性,以获得更好的癌症治疗.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在血液癌症中表现出成功,但在固体瘤中扎.
- 瘤细胞抗原异质性是CAR T细胞疗效的关键障碍,导致耐药性和复发.
研究的目的:
- 在CAR T细胞疗法中审查抗原异质性.
- 概述克服瘤抗原变异性的策略.
主要方法:
- 对当前CAR T细胞治疗方法的文献综述.
- 针对瘤抗原异质性的策略分析.
主要成果:
- 抗原异质性限制了CAR T细胞在固体瘤中的有效性,并有助于血液恶性瘤的复发.
- 确定的策略包括组合疗法,CAR结构优化,多抗原向和瘤微环境调制.
结论:
- 解决瘤抗原异质性对于推进CAR T细胞疗法至关重要.
- 新的策略提供了有希望的方向,以提高CAR T细胞对各种癌症的疗效.
相关概念视频
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Cell-mediated Immune Responses
66.6K
Overview
66.6K
T Cell Activation and Clonal Selection
620
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
620
Antigens Involved in Adaptive Immunity
431
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
431
Diversity of Antigen Receptors
475
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
475
Cells of the Adaptive Immune Response
746
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
746


